@article{8bb0e4d4c99a496e8d0e37c40be8735d,
title = "A Mitochondrial Power Play in Lymphoma",
abstract = "Deregulated energetics is a hallmark of malignancy, but metabolic heterogeneity among individual tumors is unknown. A study by Caro et al. in this issue of Cancer Cell demonstrates that a subset of lymphomas is defined by reliance on mitochondrial energy generation and is selectively killed when this pathway is impaired.",
author = "DeBerardinis, {Ralph J.}",
note = "Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by an Investigator Initiated Trial Grant from Biogen Idec. Additional funding was provided by the ziMS Foundation. Funding Information: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: M.D.G. has received personal consultancy funds from Genzyme and Serepta; institutional consultancy and/ or research funds from Acorda, Biogen Idec, and Novartis Pharmaceuticals; and grant support from the NIH NINDS (K23NS062898). R.W.M. has consulting relationships with and/or research support from Biogen Idec, Acorda, and Sun Health Technologies. M.D.W. received funding from a Clinical Multiple Sclerosis Fellowship from the National MS Society. D.E.J. has received personal consulting fees from Novartis and Biogen Idec; institutional consulting agreements from Biogen Idec, Genzyme, and Novartis; and research support from Biogen Idec. J.H.P. reports no disclosures. D.C. is a full-time employee at Biogen and owns Biogen stock and stock options.",
year = "2012",
month = oct,
day = "16",
doi = "10.1016/j.ccr.2012.09.023",
language = "English (US)",
volume = "22",
pages = "423--424",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "4",
}